Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.11% | 1.88% | 64.06% | 64.95% | 15.61% |
| Total Depreciation and Amortization | 0.56% | 2.88% | 30.54% | 27.36% | -50.96% |
| Total Amortization of Deferred Charges | -31.68% | -30.12% | -- | -- | -- |
| Total Other Non-Cash Items | 1,860.36% | 1,916.22% | -103.33% | -103.24% | -96.30% |
| Change in Net Operating Assets | -- | -- | -1,116.93% | -1,091.42% | -- |
| Cash from Operations | 14.21% | 12.21% | -64.32% | -60.27% | 9.80% |
| Capital Expenditure | 52.06% | 50.87% | 90.48% | 90.68% | -120.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.73% | 60.83% | 5,166.67% | 5,133.33% | 74.86% |
| Cash from Investing | 55.60% | 54.57% | 116.24% | 115.70% | 42.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.39% | -5.39% | 49.59% | 49.59% | -15.97% |
| Issuance of Common Stock | -- | -- | -0.54% | -0.54% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.42% | -7.77% | 0.61% | -1.87% | -14.89% |
| Foreign Exchange rate Adjustments | -- | -- | -97.90% | -97.95% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.02% | 17.14% | -27.02% | -28.82% | 11.21% |